NPI: 1932143989 · RICHTON, MS 39476 · Rural Acute Care Hospital · NPI assigned 06/16/2006
Authorized official HESTER, BEN controls 20+ related entities in our dataset. Read more
| Authorized Official | HESTER, BEN (CFO) |
| Parent Organization | FORREST COUNTY GENERAL HOSPITAL |
| NPI Enumeration Date | 06/16/2006 |
Other providers sharing the same authorized official: HESTER, BEN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,510 | $140K |
| 2019 | 4,344 | $197K |
| 2020 | 3,886 | $122K |
| 2021 | 7,034 | $158K |
| 2022 | 8,051 | $202K |
| 2023 | 9,500 | $282K |
| 2024 | 5,672 | $255K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 5,336 | 3,730 | $500K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 1,357 | 966 | $188K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,274 | 1,679 | $138K |
| 71046 | Radiologic examination, chest; 2 views | 1,477 | 1,164 | $56K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 244 | 188 | $50K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,303 | 942 | $48K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,112 | 958 | $46K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 540 | 431 | $35K |
| 80053 | Comprehensive metabolic panel | 4,668 | 3,606 | $32K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5,640 | 4,281 | $26K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1,265 | 919 | $25K |
| 87634 | 760 | 560 | $22K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 579 | 121 | $22K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 646 | 518 | $21K |
| 70450 | Computed tomography, head or brain; without contrast material | 147 | 121 | $18K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 877 | 645 | $15K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 723 | 618 | $14K |
| 36415 | Collection of venous blood by venipuncture | 5,794 | 4,401 | $11K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 45 | 44 | $10K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 500 | 367 | $8K |
| 84443 | Thyroid stimulating hormone (TSH) | 703 | 585 | $8K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 563 | 511 | $7K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 207 | 151 | $7K |
| 80061 | Lipid panel | 735 | 600 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 371 | 283 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | 683 | 559 | $4K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 112 | 81 | $4K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 36 | 26 | $4K |
| 81000 | 1,026 | 816 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 74 | 54 | $3K |
| 87275 | 243 | 211 | $3K | |
| 87276 | 213 | 187 | $3K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 12 | 12 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | 141 | 116 | $2K |
| 71045 | Radiologic examination, chest; single view | 76 | 55 | $2K |
| 81001 | 1,287 | 948 | $2K | |
| 80305 | 206 | 162 | $2K | |
| 81025 | 315 | 221 | $1K | |
| 84484 | 296 | 167 | $1K | |
| 83880 | 30 | 27 | $839.72 | |
| 74018 | 23 | 12 | $784.82 | |
| 73030 | 12 | 12 | $543.28 | |
| 0012A | 16 | 16 | $408.50 | |
| 81002 | 173 | 149 | $391.19 | |
| 96361 | Intravenous infusion, hydration; each additional hour | 19 | 15 | $365.38 |
| 0031A | 18 | 13 | $341.29 | |
| 99454 | 47 | 34 | $301.09 | |
| 0011A | 17 | 17 | $239.00 | |
| 82553 | 37 | 14 | $212.09 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 257 | 194 | $92.81 |
| 36592 | 55 | 37 | $79.54 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 12 | 12 | $59.28 |
| 83690 | 19 | 17 | $48.09 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 108 | 82 | $16.13 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 14 | 12 | $4.20 |
| 99458 | 42 | 29 | $0.00 | |
| 91301 | 13 | 13 | $0.00 | |
| 99457 | 42 | 29 | $0.00 | |
| S9110 | Telemonitoring of patient in their home, including all necessary equipment; computer system, connections, and software; maintenance; patient education and support; per month | 457 | 33 | $0.00 |